This study was used for assessing the usefulness of anti-TNF-α (infliximab, adalimumab) in the treatment of depression and psoriasis. However, they were found to be effective in treating depression and associated with chronic inflammatory conditions. The gene discussed is TNF; the disease is psoriasis.